About us
BIFIDO Co.,
Ltd. was founded in 1999, in the spirit of challenge to pursue the best
biotechnology and be the best in the field of the human microbiome.
Among various
intestinal microbiome, Bifidobacterium is considered to be the most
beneficial bacterium to maintain healthy intestinal microbial balance. BIFIDO
has focused on research and development of Bifidobacterium spp. since
1999. Over 250 related scientific papers and 80 patents prove that BIFIDO is
the top-tier company with the greatest experience and expertise in the
microbiome industry.
Recently,
BIFIDO started microbiome research on rheumatoid arthritis (RA), a chronic
inflammatory disease. We analyzed the microbiota of RA patients and tried to
find a way to treat even those who were less responsive to treatment. We have
selected novel Bifidobacterium strains that can improve the symptoms of
RA in animal models, and we expect new pharmabiotics from those strains. We are
now expanding our pipelines for other immune-related diseases, including cancer.
Specs about this supplier
| Sales markets | Asia; Australia; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Affiliated categories: | Functional Food |Private label/Bespoke products |Probiotics More |
Products featured at Vitafoods Europe 2025
-
Bifidobacterium bifidum BGN4
-
Bifidobacterium lactis AD011
-
Bifidobacterium longum BORI
-
Dr.G Bifidus
-
Dr.G Bifidus Baby
-
Dr.G Synbiotics
-
L.acidophilus AD031
-
Lactobacillus casei IBS041
-
Lactobacillus paracasei CH88
-
Premix Probiotics GNL
-
Premix Probiotics PAI
-
Zigunuk Bifidus Baby Premium
-
Zigunuk Bifidus Premium
-
Zigunuk Bifidus Pro g